Cedar Clinical Research

Draper, Utah 84020

4 studies enrolling now · 20 studies all time

What they study most

Anxiety Generalized, Autism Spectrum Disorder, Cannabis Withdrawal, Depressive Disorder, Major, Generalized Anxiety Disorder, Major Depressive Disorder, Marijuana Abuse, Post Traumatic Stress Disorder, Schizophrenia, Social Anxiety Disorder (SAD), Tourette Disorder, Tourette Syndrome

Studies at this site

• A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend) — Recruiting now
• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms — Recruiting now
• RE104 Safety and Efficacy Study in Generalized Anxiety Disorder — Recruiting now
• An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1) — Recruiting now
• Psilocybin for Major Depressive Disorder (MDD) — Running, not enrolling
• A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder — Running, not enrolling
• Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) — Enrolling by invitation
• A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage) — Running, not enrolling
• Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults — Completed
• ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD) — Completed
• A Study of Psilocybin for Major Depressive Disorder (MDD) — Completed
• A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms — Completed
• Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD — Running, not enrolling
• Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD — Running, not enrolling
• An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5) — Completed
• A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy — Completed
• BPL-003 Efficacy and Safety in Treatment Resistant Depression — Completed
• A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder. — Completed
• Effect of PP-01 on Cannabis Withdrawal Syndrome — Completed
• Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD) — Completed